Epidermal Growth Factor Receptor Antagonist [EPC]

47292 reported adverse events

Drugs of this class: CETUXIMAB PANITUMUMAB

These side effects are most commonly reported by patients taking drugs of the Epidermal Growth Factor Receptor Antagonist [EPC] class:

# Side effect Count
0 RASH 4217
1 DIARRHOEA 3612
2 OFF LABEL USE 2628
3 NAUSEA 2482
4 NEUTROPENIA 2144
5 DEATH 2064
6 VOMITING 2034
7 DERMATITIS ACNEIFORM 1889
8 DYSPNOEA 1775
9 FATIGUE 1771
See all common reactions for Epidermal Growth Factor Receptor Antagonist [EPC]

Drugs of the Epidermal Growth Factor Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COLORECTAL CANCER METASTATIC 923 0.3891
1 DERMATITIS ACNEIFORM 1889 0.3101
2 SKIN TOXICITY 1257 0.2222
3 RADIATION SKIN INJURY 222 0.1914
4 PARONYCHIA 821 0.1866
5 SEROUS RETINAL DETACHMENT 107 0.1277
6 HYPOMAGNESAEMIA 1426 0.1023
7 ACNE PUSTULAR 67 0.0817
8 COLON CANCER METASTATIC 126 0.0781
9 CARCINOEMBRYONIC ANTIGEN INCREASED 150 0.0774
See all enriched reactions for Epidermal Growth Factor Receptor Antagonist [EPC]